Zobrazeno 1 - 7
of 7
pro vyhledávání: '"RM Falk"'
Autor:
X. Segarra, A. Prusinski, J. Pascual, P. Ferrer, J. Jelencsik, RM Falk, X. Cabarrocas, R. Docekal, X. Luria
Publikováno v:
European Neurology. 45:206-213
Background: Almotriptan is a highly specific 5-HT1B/1D receptor agonist, which acts selectively on blood vessels of the brain. Short-term studies have demonstrated that almotriptan provides rapid, effective and reliable relief of migraine attacks, wh
Autor:
M Robert, P Docekal, A. Prusinski, RM Falk, X. Luria, J. Pascual, P. Ferrer, F Piessens, R Segarra, JM Zayas
Publikováno v:
Cephalalgia. 20:588-596
In this double-blind study, the efficacy and tolerability of a single dose of almotriptan (6.25 or 12.5 mg) was compared with placebo in the treatment of three consecutive migraine attacks of moderate or severe intensity. Of 1013 randomized patients,
Autor:
Pascual J; Servicio de Neurología, University Hospital, Santander, Spain. pascualj@medi.unican.es, Falk RM, Piessens F, Prusinski A, Docekal P, Robert M, Ferrer P, Luria X, Segarra R, Zayas JM
Publikováno v:
Cephalalgia : an international journal of headache [Cephalalgia] 2000 Jul; Vol. 20 (6), pp. 588-96.
Autor:
Grantmyre JE; Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA., Thomas AJ Jr, Falk RM, Wazzan W, Houlihan D, Coburn M, Lipshultz LI, Belker AM, Nagler HM
Publikováno v:
Fertility and sterility [Fertil Steril] 1995 Jul; Vol. 64 (1), pp. 179-84.
Autor:
Dewire DM; Department of Urology, Cleveland Clinic Foundation, Ohio 44195., Thomas AJ Jr, Falk RM, Geisinger MA, Lammert GK
Publikováno v:
Journal of andrology [J Androl] 1994 Nov-Dec; Vol. 15 Suppl, pp. 38S-42S.
Autor:
Falk RM; Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee 37232., Silverberg KM, Fetterolf PM, Kirchner FK, Rogers BJ
Publikováno v:
Fertility and sterility [Fertil Steril] 1990 Jul; Vol. 54 (1), pp. 121-6.
Publikováno v:
The Journal of urology [J Urol] 1985 Oct; Vol. 134 (4), pp. 716-9.